William Blair downgraded Udemy (UDMY) to Market Perform from Outperform after the company announced the appointment of Hugo Sarrazin as ...

The embedded finance company, which posted a loss last year, hired Citigroup to explore its strategic options and named an ...

William Blair analyst Dylan Carden maintained a Hold rating on Allbirds (BIRD – Research Report) today. The company’s shares closed yesterday ...

The embedded payments and digital card company agreed to buy European electronic payments provider TransactPay for about $47 ...

Investment analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for shares of Biodesix in a research note issued on Tuesday, March 4th. William Blair analyst A. Brackmann ...

Equities researchers at William Blair issued their FY2029 earnings per share (EPS) estimates for shares of Intellia ...

The one-time therapy appears to correct the mutation that causes the disease, known as Alpha-1 antitrypsin deficiency (AATD), ...

Legend Biotech is building a new $150 million manufacturing plant, with its partner Johnson & Johnson, with the goal of ...

Wall Street loves CEO Hock Tan's M&A strategy and his aggressive moves to boost profitability at VMware.

Citi analysts increased their price target on Docusign to $115 from $113 and reiterated a Buy rating. “Revenue was a bit ...

Dealmakers had expected a “Trump bump” to help reignite mergers. But tariffs, declining consumer confidence and stock market ...

Analysts acknowledged the long-term manufacturing deal could dull Viking’s takeout prospects but hailed it as a smart move to ensure supply.